Targets for inhibition of hepatitis C virus replication.
Considerable progress has been made in characterizing the proteins involved in hepatitis C virus (HCV) replication, despite the lack of a cell culture system. A number of systems have been developed to examine the processes involved in viral replication, including the initiation and processing of the viral proteins required for RNA replication, the unwinding activities of the RNA helicase and the synthesis of RNA by the viral polymerase. These processes have been examined using individually cloned proteins expressed in various in vitro systems, which may be suitable targets for antiviral agents. The viral helicase and protease domains have now been crystallized, which may enable the rational design of specific inhibitors. The recent developments in HCV research in understanding the function of the viral non-structural proteins and the establishment of in vitro screening assays may aid in the development of new antiviral agents.
Littlejohn
M
M
Victorian Infectious Diseases Reference Laboratory, North Melbourne, Australia.
Locarnini
S
S
Bartholomeusz
A
A
D000998:Antiviral Agents / Q000494:pharmacology; D002478:Cells, Cultured; D012321:DNA-Directed RNA Polymerases / Q000494:pharmacology; D005416:Flavivirus / Q000235:genetics; D016174:Hepacivirus / Q000201:enzymology* / Q000235:genetics; D006801:Humans; D020365:RNA Helicases / Q000494:pharmacology; D012367:RNA, Viral / Q000032:analysis / Q000096:biosynthesis; D014158:Transcription, Genetic / Q000187:drug effects; D017361:Viral Nonstructural Proteins / Q000502:physiology; D014779:Virus Replication / Q000187:drug effects / Q000235:genetics / Q000502:physiology*
D000998:Antiviral Agents; D012367:RNA, Viral; D017361:Viral Nonstructural Proteins; D012321:DNA-Directed RNA Polymerases; D020365:RNA Helicases